Immunomodulatory effectiveness of licofelone in preventing epidural fibrosis in post-laminectomy rat
Related Experiment Video
Updated: Apr 24, 2026
Laminectomy and Spinal Cord Window Implantation in the Mouse
Published on: October 23, 2019
Kun Zhang1, Jinmin Zhao, Wei Su
1Department of Orthopedic Trauma and Hand Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, China.
Insights
Licofelone effectively prevents epidural fibrosis (EF) formation and reduces inflammation in post-laminectomy rat models. This study demonstrates its potential for reducing scar tissue and adhesions after spinal surgery.
Area of Science:
- Spinal Surgery
- Regenerative Medicine
- Pharmacology
Background:
- Epidural fibrosis (EF) is a common complication following laminectomy, leading to scar tissue formation and potential adhesions.
- Current treatments for EF have limitations, necessitating the exploration of novel therapeutic agents.
Purpose of the Study:
- To investigate the efficacy of licofelone in preventing epidural fibrosis (EF) in a post-laminectomy rat model.
- To evaluate the impact of licofelone on key biochemical and histological markers associated with EF.
Main Methods:
- A double-blinded, controlled study involving 60 Wistar rats undergoing laminectomy at L1-L2.
- Rats were randomized into three groups: licofelone treatment, vehicle control, and sham.
- Assessment included macroscopic evaluation, hydroxyproline content, histological analysis, and mRNA expression of IL-6 and TGF-β1.
Main Results:
- Licofelone treatment significantly reduced the Rydell score, indicating less severe EF.
- Hydroxyproline content and epidural scar density were lower in the licofelone group.
- Reduced expression of inflammatory factors (IL-6, TGF-β1) was observed with licofelone treatment.
Conclusions:
- Licofelone demonstrates significant potential in preventing epidural fibrosis and adhesions post-laminectomy.
- The drug effectively reduces hydroxyproline deposition and inflammatory mediator expression.
- These findings suggest licofelone as a promising therapeutic agent for mitigating post-surgical spinal complications.
Objective:
The object of this study was to investigate the effects of licofelone on the prevention of epidural fibrosis (EF) formation in post-laminectomy rat models.
Methods:
A controlled double-blinded study was conducted in sixty, healthy adult Wistar rats that underwent laminectomy at the L1-L2 vertebrae levels. All the rats were divided randomly into three groups according to the treatment (via oral gavage): (1) licofelone treatment group; (2) vehicle treatment group; (3) sham group (laminectomy without treatment). All rats were euthanized humanely 4 weeks postoperatively. The macroscopic assessment of EF, hydroxyproline content in epidural scar tissue, histological analysis, and the mRNA measurements of interleukin-6 (IL-6) and transforming growth factor-β1 were performed.
Results:
The Rydell score, hydroxyproline content, epidural scar density, and inflammatory factors expressions all suggested better results in licofelone group than the other two groups.
Conclusion:
The application of licofelone could reduce hydroxyproline deposits, inflammatory factors expressions and prevent epidural adhesions in post-laminectomy rats.
